298 related articles for article (PubMed ID: 32320410)
21. Structure and assembly of the SF3a splicing factor complex of U2 snRNP.
Lin PC; Xu RM
EMBO J; 2012 Mar; 31(6):1579-90. PubMed ID: 22314233
[TBL] [Abstract][Full Text] [Related]
22. Domain Requirements and Genetic Interactions of the Mud1 Subunit of the
Agarwal R; Schwer B; Shuman S
G3 (Bethesda); 2019 Jan; 9(1):145-151. PubMed ID: 30413416
[TBL] [Abstract][Full Text] [Related]
23. Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.
Effenberger KA; Urabe VK; Prichard BE; Ghosh AK; Jurica MS
RNA; 2016 Mar; 22(3):350-9. PubMed ID: 26742993
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Malcovati L; Papaemmanuil E; Bowen DT; Boultwood J; Della Porta MG; Pascutto C; Travaglino E; Groves MJ; Godfrey AL; Ambaglio I; Gallì A; Da Vià MC; Conte S; Tauro S; Keenan N; Hyslop A; Hinton J; Mudie LJ; Wainscoat JS; Futreal PA; Stratton MR; Campbell PJ; Hellström-Lindberg E; Cazzola M;
Blood; 2011 Dec; 118(24):6239-46. PubMed ID: 21998214
[TBL] [Abstract][Full Text] [Related]
25. Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia.
Wang C; Sashida G; Saraya A; Ishiga R; Koide S; Oshima M; Isono K; Koseki H; Iwama A
Blood; 2014 May; 123(21):3336-43. PubMed ID: 24735968
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
[TBL] [Abstract][Full Text] [Related]
27. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
Zhang J; Ali AM; Lieu YK; Liu Z; Gao J; Rabadan R; Raza A; Mukherjee S; Manley JL
Mol Cell; 2019 Oct; 76(1):82-95.e7. PubMed ID: 31474574
[TBL] [Abstract][Full Text] [Related]
28. The histone variant H2A.Z promotes efficient cotranscriptional splicing in
Neves LT; Douglass S; Spreafico R; Venkataramanan S; Kress TL; Johnson TL
Genes Dev; 2017 Apr; 31(7):702-717. PubMed ID: 28446598
[TBL] [Abstract][Full Text] [Related]
29. The splicing factor Prp17 interacts with the U2, U5 and U6 snRNPs and associates with the spliceosome pre- and post-catalysis.
Sapra AK; Khandelia P; Vijayraghavan U
Biochem J; 2008 Dec; 416(3):365-74. PubMed ID: 18691155
[TBL] [Abstract][Full Text] [Related]
30. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
31. [Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases].
Wang JY; Ma J; Lin YN; Wang J; Shen H; Gui FM; Han C; Li QH; Song Z; Wang XJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):192-197. PubMed ID: 28395441
[No Abstract] [Full Text] [Related]
32. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
33. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Dolatshad H; Pellagatti A; Fernandez-Mercado M; Yip BH; Malcovati L; Attwood M; Przychodzen B; Sahgal N; Kanapin AA; Lockstone H; Scifo L; Vandenberghe P; Papaemmanuil E; Smith CW; Campbell PJ; Ogawa S; Maciejewski JP; Cazzola M; Savage KI; Boultwood J
Leukemia; 2015 May; 29(5):1092-103. PubMed ID: 25428262
[TBL] [Abstract][Full Text] [Related]
34. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870
[TBL] [Abstract][Full Text] [Related]
35. SF3B1 association with chromatin determines splicing outcomes.
Kfir N; Lev-Maor G; Glaich O; Alajem A; Datta A; Sze SK; Meshorer E; Ast G
Cell Rep; 2015 Apr; 11(4):618-29. PubMed ID: 25892229
[TBL] [Abstract][Full Text] [Related]
36. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
37. SF3B1 mutations in chronic lymphocytic leukemia.
Wan Y; Wu CJ
Blood; 2013 Jun; 121(23):4627-34. PubMed ID: 23568491
[TBL] [Abstract][Full Text] [Related]
38. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis.
Wang C; Chua K; Seghezzi W; Lees E; Gozani O; Reed R
Genes Dev; 1998 May; 12(10):1409-14. PubMed ID: 9585501
[TBL] [Abstract][Full Text] [Related]
40. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]